| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Interest income: |
| Interest income on loans | 251.5 | 254.4 | 250.5 | 200.0 | 153.8 | 119.2 | 94.5 | 63.6 |
| Interest income on investments | 29.8 | 30.2 | 35.9 | 38.7 | 35.4 | 27.2 | 20.9 | 15.7 |
| | 284.2 | 287.0 | 289.8 | 241.4 | 191.6 | 148.1 | 116.4 | 80.3 |
| Interest expense: |
| | 8.2 | 24.3 | 46.2 | 29.9 | 15.3 | 8.5 | 6.9 | 5.4 |
| Net interest income | 276.0 | 262.7 | 243.6 | 211.5 | 176.3 | 139.6 | 109.5 | 74.9 |
| Provision for loan losses | -9.4 | 38.2 | 11.0 | 11.7 | 5.6 | 2.4 | 2.6 | -3.5 |
| Net interest income after provision for loan losses | 285.4 | 224.6 | 232.6 | 199.8 | 170.6 | 137.2 | 106.8 | 78.4 |
| Deposit and loan fees | 9.8 | 9.4 | 11.5 | | | 9.7 | 8.6 | 7.0 |
| Gain on sale of investments, net | -0.6 | 1.2 | 1.2 | -0.6 | 0.1 | 0.4 | 0.2 | 0.5 |
| Other non-interest income | 61.5 | 50.9 | 44.0 | 105.0 | 58.4 | 88.8 | 75.6 | 57.9 |
| Total non-interest income | 70.7 | 61.6 | 56.7 | 104.3 | 58.5 | 98.8 | 84.3 | 65.3 |
| Non-interest expenses | 197.4 | 185.6 | 160.7 | 162.3 | 149.9 | 130.9 | 103.8 | 93.4 |
| Pre-tax income | 158.7 | 100.6 | 128.6 | 87.5 | 79.2 | 44.1 | 35.7 | 10.2 |
| Income taxes | 34.3 | 22.8 | 29.9 | 20.3 | 36.3 | 14.9 | 13.5 | 4.5 |
| Tax rate | 21.6% | 22.7% | 23.2% | 23.1% | 45.9% | 33.8% | 37.9% | 44.4% |
| Net income | 124.4 | 77.8 | 98.7 | 67.3 | 42.9 | 29.2 | 22.1 | 5.7 |
| Net margin | 34.9% | 27.2% | 34.1% | 22.1% | 18.7% | 12.4% | 11.6% | 4.0% |
| |
| Basic EPS | $2.20 | $1.45 | $1.92 | $1.40 | $1.01 | $0.79 | $0.66 | $0.21 |
| Diluted EPS | $2.18 | $1.44 | $1.90 | $1.38 | $0.99 | $0.78 | $0.66 | $0.21 |
| |
| Shares outstanding (basic) | 56.6 | 53.5 | 51.4 | 48.0 | 42.6 | 36.9 | 33.5 | 27.5 |
| Shares outstanding (diluted) | 57.1 | 53.9 | 52.0 | 48.7 | 43.4 | 37.5 | 33.7 | 27.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |